Cartesian Therapeutics, Inc. Income Statement

Income Statement Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 3.04M6.01M8.08M0.21M0.90M6.68M16.60M85.08M110.78M26.00M38.91M
Gross Profit 3.04M6.01M8.08M0.21M0.90M6.68M16.60M85.08M110.78M26.00M38.91M
Operating items
Research & Development 10.49M22.98M29.70M45.16M47.69M42.74M54.51M68.74M72.38M71.26M45.10M
Selling, General & Administrative 7.95M8.34M13.05M18.83M18.24M16.39M18.91M20.94M23.86M40.45M30.13M
Other Operating Expenses 0.71M7.58M
Operating Expenses 18.44M31.32M42.75M63.99M65.92M59.13M73.42M89.67M96.24M112.42M82.81M
Operating Income -15.40M-25.30M-34.67M-63.78M-65.02M-52.45M-56.82M-4.60M14.54M-86.42M-43.90M
EBIT -15.40M-25.30M-34.67M-63.78M-65.02M-52.45M-56.82M-4.60M14.54M-86.42M-43.90M
Non-operating items
Non Operating Investment Income -149.60M-6.89M
Interest & Investment Income 0.11M0.17M0.23M0.62M1.05M0.83M0.26M0.04M2.07M4.96M7.39M
Other Non Operating Income 3.00M0.93M-0.53M-0.67M0.12M-1.31M-0.46M0.01M0.33M0.69M0.61M
Non Operating Income -0.04M-0.03M0.00M-0.15M0.01M-1.31M0.09M0.01M0.33M0.69M0.61M
Net income details
EBT -15.84M-26.08M-35.69M-64.37M-65.47M-55.35M-68.88M-9.72M34.77M-238.71M-77.14M
Tax Provisions 15.97M-0.61M-19.00M0.29M
Profit After Tax -12.88M-25.17M-36.21M-65.32M-65.34M-55.35M-68.88M-25.69M35.38M-219.71M-77.42M
Income from Continuing Operations -15.84M-26.08M-35.69M-64.37M-65.47M-55.35M-68.88M-25.69M35.38M-219.71M-77.42M
Consolidated Net Income -15.84M-26.08M-35.69M-64.37M-65.47M-55.35M-68.88M-25.69M35.38M-219.71M-77.42M
Income towards Parent Company -15.84M-26.08M-35.69M-64.37M-65.47M-55.35M-68.88M-25.69M35.38M-219.71M-77.42M
Preferred Dividend Payments 4.95M7.33M4.57M
Net Income towards Common Stockholders -16.37M-32.51M-40.78M-65.32M-65.34M-55.35M-68.88M-25.69M35.38M-219.71M-77.42M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 0.61M0.74M0.75M1.61M3.60M3.89M5.10M5.17M25.41M
Shares Outstanding (Diluted Average) 45.55M101.20M114.33M145.87M5.17M17.36M
EBITDA -16.16M-26.28M-35.74M-65.22M-65.47M-55.32M-68.92M-25.69M35.39M-219.75M-77.44M
Tax Rate 7.96%